IP Library Granted Patent US 9,359,629
Granted Patent B2
US 9,359,629 · App. 12/341,807 · Granted Jun 7, 2016

Cell culture processes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,359,629
App. No.
12/341,807
Granted
Jun 7, 2016
Kind
B2
Abstract

Culturing heterologous protein-secreting mammalian cells, such as CHO or BHK cells, at 35.1-36.5° C. and/or at pH 7.15-7.20 and/or at a dissolved CO 2 concentration of 10% or lower. Preferred heterologous proteins are Factor VIII, ADAMTS-13, furin or Factor VII.

Claims (29)

1. A method comprising:

expressing heterologous Factor VIII protein in a mammalian cell in continuous cell culture wherein the continuous cell culture is maintained at a temperature of 36.0±0.5° C. and a cell culture density of from 1.4×10 6 to 2.6×10 6 cells/ml, and wherein the mammalian cell is a CHO cell.

2. The method of claim 1 , wherein the temperature of the continuous cell culture is maintained at 36±0.2° C.

3. The method of claim 1 , wherein the temperature of the continuous cell culture is maintained at 36° C.

4. The method of claim 1 , wherein the temperature of the continuous cell culture is maintained at 36.5° C.

5. The method of claim 1 , wherein the continuous cell culture is maintained at a pH of from 7.10 to 7.25.

6. The method of claim 5 , wherein the pH of the continuous cell culture is maintained at 7.20±0.05.

7. The method of claim 5 , wherein the pH of the continuous cell culture is maintained at 7.20±0.03.

8. The method of claim 5 , wherein the pH of the continuous cell culture is maintained at 7.20±0.01.

9. The method of claim 5 , wherein the pH of the continuous cell culture is maintained at 7.20.

10. The method of claim 5 , wherein the pH of the continuous cell culture is maintained at 7.15±0.05.

11. The method of claim 5 , wherein the pH of the continuous cell culture is maintained at 7.15±0.03.

12. The method of claim 5 , wherein the pH of the continuous cell culture is maintained at 7.15±0.01.

13. The method of claim 5 , wherein the pH of the continuous cell culture is maintained at 7.15.

14. The method of claim 1 , wherein the continuous cell culture is maintained at a dissolved CO 2 concentration of from 1% to 10%.

15. The method of claim 14 , wherein the CO 2 concentration of the continuous cell culture is maintained at from 4.0% to 9.0%.

16. The method of claim 14 , wherein the CO 2 concentration of the continuous cell culture is maintained at from 5.5% to 8.5%.

17. The method of claim 14 , wherein the continuous cell culture is maintained at a pH of from 7.10 to 7.25.

18. The method of claim 17 , wherein the cell culture supernatant of the continuous cell culture is buffered with bicarbonate.

19. The method of claim 14 , wherein the dissolved CO 2 concentration of the continuous cell culture is maintained by sparging the continuous mammalian cell culture with air.

20. The method of claim 1 , wherein the cell density of the continuous cell culture is maintained at from 1.6×10 6 to 2.6×10 6 cells/ml.

21. The method of claim 20 , wherein the cell density of the continuous cell culture is maintained at from 1.8×10 6 to 2.4×10 6 cells/ml.

22. The method of claim 1 , wherein the Factor VIII is coexpressed with von Willebrand Factor.

23. The method of any one of claims 1 , 5 , or 14 , wherein the cell culture supernatant of the continuous cell culture comprises copper (Cu 2+ ) at a concentration of at least 5 ppb.

24. The method of claim 23 , wherein the Cu 2+ concentration of the cell culture supernatant is at least 7 ppb.

25. The method of claim 1 , wherein the heterologous protein is FVIII, and the cell culture density of the continuous cell culture is maintained by:

measuring the cell culture density of the continuous cell culture using an in-line sensor, and

automatically controlling the influx of fresh medium into the continuous cell culture to maintain the cell culture density of from 1.4×10 6 to 2.6×10 6 cells/ml.

26. The method of claim 1 , wherein the continuous cell culture is operated as a chemostat or a turbidostat continuous cell culture.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0005 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036367/0652 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036375/0542 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2009
From: GIOVAGNOLI, ANDRE; ROY, SYLVAIN; DUCROS, VERONIQUE; CHARLOT, VIRGINIE; STAUFFER, YVES-OLIVIER
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 022762/0226 →